Physician profile
Daniel Jeong
NPI 1922273036
$12,318.41
in general payments reported to CMS, 2019-2025
5 companies · $3,778 in 2025
The $3,778 reported for 2025 was more than what 96% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $1,098 · 2021: $706 · 2022: $1,579 · 2023: $1,425 · 2024: $3,053 · 2025: $3,778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,153 · Food and Beverage: $3,349 · Education: $400 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $252 · Gift: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,153.24 |
| Food and Beverage | $3,348.92 |
| Education | $400.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $251.82 |
| Gift | $101.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $7,839.58 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $2,614.82 | 2019-2022 | |
| Straumann USA LLC | $1,736.09 | 2021-2025 | |
| Henry Schein, INC. | $111.84 | 2024 | |
| Zest Holdings, LLC | $16.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Jeong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.